# Specialised - Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema

> Pre-procurement notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS ENGLAND](/buyers/nhs-england/contract-awards)
- Tender value: £15,000,000
- Published: 13 December 2019
- Planned start: 1 January 2021
- Planned end: 31 December 2021
- Stage: pre_procurement
- Notice ID: 05be086b-0a67-48c1-9f15-30b42bcd348b-332206
- OCID: ocds-b5fd17-76fe727e-9816-4a66-bc9c-c1acb016e466

## Description

Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/05be086b-0a67-48c1-9f15-30b42bcd348b-332206)